Revium Rx (RVRC) Total Liabilities (2024 - 2026)
Revium Rx's (RVRC) quarterly Total Liabilities came in at $1.6 million in Q2 2026, up 108.58% year-over-year from $762289.9 in Q2 2025, and up 11.97% quarter-over-quarter from $1.4 million in Q4 2025.
Analysis
Revium Rx (RVRC) Total Liabilities (2024 - 2026) Analysis & Trends
Revium Rx has disclosed Total Liabilities across 3 years of filings, most recently posting $1.6 million for Q2 2026.
- In Q2 2026, Total Liabilities rose 108.58% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $1.6 million (up 108.58% YoY), while the FY2025 annual figure was $1.4 million, up 146.53% from the prior year.
- Total Liabilities came in at $1.6 million for Q2 2026 at Revium Rx, up from $1.4 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.6 million in Q2 2026 to a low of -$18.5 million in Q2 2025.
- Average Total Liabilities over 3 years is -$3.7 million, with a median of $998000.0 recorded in 2024.
- Year-over-year, Total Liabilities jumped 146.53% in 2025 and surged 108.58% in 2026.
- Over 3 years, Total Liabilities stood at $576000.0 in 2024, then jumped by 146.53% to $1.4 million in 2025, then increased by 11.97% to $1.6 million in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $1.6 million in Q2 2026, $1.4 million in Q4 2025, and -$18.5 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 83.95 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 37.53 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 7.18 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 10.02 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 1.62 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 4.20 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 13.24 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Revium Rx | 86.84 Mn | 85.34 Mn | - | 1.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Mn |
| Dec 31, 2025 | 1.42 Mn |
| Jun 30, 2025 | -18.53 Mn |
| Dec 31, 2024 | 576,000.00 |